Why the study?
Hypertension causes end-organ damage and complex comorbidities in the elderly, who also face reduced physiological capacity and the adverse effects of frailty.
Comprehensive assessment of frailty and target organ damage is essential before initiating antihypertensive therapy in elderly patients.
Answers are grounded in this paper and cite their sources.
Tailored hypertension care is essential in frail elderly; leaves open optimal targets and strategies from prospective trials.
The lifetime risk of incident hypertension is approximately 90%. Hypertension is the most important cardiovascular risk factor, and is readily modifiable. Hypertension can cause end-organ damage and consequently contribute to multiple comorbidities and complexity of treatment for the elderly. Elderly people have reduced physiological and psychological capacities, increased vulnerability to various stresses, and the adverse effects of frailty. When treating hypertension in the elderly, complete and systemic assessments should be performed before starting any medication. Interventions should always consider the balance between their advantages and potential drawbacks. In this review, we examined the existing evidence regarding damage to vital organs and the state of frailty in elderly patients with hypertension.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: